Biogen Inc. (BIIB) stock
BIIBNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 28, 2026Score 4/3056% above fair value
$250.79−0.86 (-0.34%)
Close on Nov 17, 2026Market cap $37.07BP/E 107.2Yield –
Biogen operating margin
Operating margin is operating income as a percentage of revenue.
Biogen's operating margin for the twelve months ending Mar 31, 2022 was 22.9%. For fiscal 2021 it was 25.9%, against 33.8% the year before. The highest annual figure on record is 49.0% in fiscal 2019.
Annual operating margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2021 | Dec 31, 2021 | 25.9% | −8.0 |
| FY2020 | Dec 31, 2020 | 33.8% | −15.1 |
| FY2019 | Dec 31, 2019 | 49.0% | +5.2 |
| FY2018 | Dec 31, 2018 | 43.8% | +0.2 |
| FY2017 | Dec 31, 2017 | 43.6% | −1.4 |
| FY2016 | Dec 31, 2016 | 45.0% | −0.4 |
| FY2015 | Dec 31, 2015 | 45.4% | +4.5 |
| FY2014 | Dec 31, 2014 | 40.9% | +4.7 |
| FY2013 | Dec 31, 2013 | 36.3% | +2.6 |
| FY2012 | Dec 31, 2012 | 33.6% | −0.5 |
| FY2011 | Dec 31, 2011 | 34.2% | +7.7 |
| FY2010 | Dec 31, 2010 | 26.5% | −3.1 |
| FY2009 | Dec 31, 2009 | 29.6% | −0.0 |
| FY2008 | Dec 31, 2008 | 29.6% | +5.0 |
| FY2007 | Dec 31, 2007 | 24.6% | – |
Quarterly operating margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q1 FY2022 | Mar 31, 2022 | 24.1% | −12.0 |
| Q4 FY2021 | Dec 31, 2021 | 21.5% | +33.1 |
| Q3 FY2021 | Sep 30, 2021 | 28.6% | −3.6 |
| Q2 FY2021 | Jun 30, 2021 | 17.5% | −36.1 |
| Q1 FY2021 | Mar 31, 2021 | 36.2% | −15.3 |
| Q4 FY2020 | Dec 31, 2020 | -11.6% | −60.0 |
| Q3 FY2020 | Sep 30, 2020 | 32.2% | −18.0 |
| Q2 FY2020 | Jun 30, 2020 | 53.6% | −0.4 |
| Q1 FY2020 | Mar 31, 2020 | 51.5% | +8.4 |
| Q4 FY2019 | Dec 31, 2019 | 48.4% | +7.5 |
| Q3 FY2019 | Sep 30, 2019 | 50.2% | +0.8 |
| Q2 FY2019 | Jun 30, 2019 | 54.1% | +17.9 |
| Q1 FY2019 | Mar 31, 2019 | 43.1% | −6.0 |
| Q4 FY2018 | Dec 31, 2018 | 40.9% | −3.4 |
| Q3 FY2018 | Sep 30, 2018 | 49.4% | −4.4 |
| Q2 FY2018 | Jun 30, 2018 | 36.1% | −2.9 |
| Q1 FY2018 | Mar 31, 2018 | 49.0% | +12.6 |
| Q4 FY2017 | Dec 31, 2017 | 44.3% | +13.4 |
| Q3 FY2017 | Sep 30, 2017 | 53.7% | – |
| Q2 FY2017 | Jun 30, 2017 | 39.0% | – |
| Q1 FY2017 | Mar 31, 2017 | 36.5% | – |
| Q4 FY2016 | Dec 31, 2016 | 30.9% | – |
See a number that looks wrong?